Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome
Clinical trial NCT03184584 · TERMINATED
Trial details
- NCT number
- NCT03184584
- Sponsor
- Liminal BioSciences Ltd.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2020-05-08
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.